67 results
Page 3 of 4
8-K
r6dsjpgc tksra
15 Apr 21
Other Events
7:00am
8-K
EX-99.1
9rbm8j
18 Mar 21
Sutro Biopharma Reports Full Year 2020 Financial Results
7:00am
424B5
e1ap722
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
wa7gnlqis
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
EX-99.1
lce9fm
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
fkp7 6njv1arxl0yl
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
qnglrr
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.2
5bppdby
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
q79f6o7ccycyez8so6
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
f65ixk
5 Nov 20
Sutro Biopharma Reports Third Quarter 2020 Financial Results
7:05am
8-K
EX-99.1
bwi3oav74o
9 Sep 20
Other Events
5:23pm
8-K
EX-99.2
m6gfl 82akh
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
go0nv1m7x2yly
6 Aug 20
Sutro Biopharma Reports Second Quarter 2020 Financial Results
7:03am
8-K
EX-99.1
k029e 9z2l6vp
15 Jun 20
Regulation FD Disclosure
7:21am
424B5
oop uyh2upsl
12 May 20
Prospectus supplement for primary offering
5:02pm